Page last updated: 2024-10-18

gamma-butyrobetaine and Cardiovascular Diseases

gamma-butyrobetaine has been researched along with Cardiovascular Diseases in 2 studies

4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eyupoglu, ND1
Caliskan Guzelce, E1
Acikgoz, A1
Uyanik, E1
Bjørndal, B1
Berge, RK2
Svardal, A2
Yildiz, BO1
Trøseid, M1
Hov, JR1
Nestvold, TK1
Thoresen, H1
Lappegård, KT1

Other Studies

2 other studies available for gamma-butyrobetaine and Cardiovascular Diseases

ArticleYear
Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
    Clinical endocrinology, 2019, Volume: 91, Issue:6

    Topics: Adolescent; Adult; Betaine; Blood Glucose; Cardiovascular Diseases; Carnitine; Choline; Female; Gast

2019
Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Metabolic syndrome and related disorders, 2016, Volume: 14, Issue:4

    Topics: Adult; Atherosclerosis; Bariatric Surgery; Betaine; Body Mass Index; Cardiovascular Diseases; Carnit

2016